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Aflatoxin B1 (AFB1) is a mycotoxin produced by Aspergilus 
flavus and A. parasiticus identified by the International Agency 
for Research on Cancer (2012) as a group 1 carcinogenic agent 
for humans and animals. The indirect milk contamination 
by mycotoxins occurs by contaminated food consumption 
by lactating animals allowing for mycotoxins to be carried 
over to milk (Pimpitak et al., 2020; Zain, 2011). Mycotoxins 
are resistant to milk`s industrial processing (heat treatments, 
concentration or drying) justifying their presence at any dairy 
production chain stage, from raw material attainment to later 
industrialization stages (Ahmadi, 2020; Campagnollo et al., 2016; 
Flores-Flores et al., 2015).
AFB1 is the most prevalent aflatoxin (Bovo et al., 2014), 
among the 18 identified to date. AFB1 could suffer hepatic 
biotransformation and may be converted into aflatoxin M1 (AFM1) 
(Fazeli et al., 2009; Rushing & Selim, 2019) when ingested by 
animals. However, the literature reports that the conversion from 
AFB1 to AFM1 is only partially performed, and AFB1 remains 
detectable in the dairy matrix, reinforcing the detoxification 
study relevance (Gonçalves et al., 2018; Scaglioni et al., 2014). 
The AFM1 incidence in raw and pasteurized milk varied from 
61.5% to 100% (Ahmadi, 2020; Cagri-Mehmetoglu, 2018; 
Hajmohammadi et al., 2020; Öztürk Yilmaz & Altinci, 2019), 
and incidences of 65%, 40% and 29.6% were reported for kashar 
(type of cheese), white cheese and butter, respectively (Öztürk 
Yilmaz  &  Altinci, 2019). In the same context, the AFB1  has 
been also detected in milk and dairy products. An AFB1 
incidence of 41.7% and 13.3% were reported for pasteurized 
and UHT milk, with an AFB1 mean content of 1476 ug L
-1 and 
0.690 ug L-1, respectively (Scaglioni et al., 2014). Considering the 
aflatoxins toxicity, it important to emphasize that AFB1 is likely 
to contaminate milk and dairy products become a public health 
issue, and its evaluation is needed due to its higher resistance to 
toxicity (Zain, 2011). Thus, the study of procedures that might 
reduce AFB1 percentage and its bioaccessibility is made more 
attractive. The use of probiotics is the most commonly used 
procedure on mycotoxins decontamination as the lactic acid 
bacteria species may adsorb mycotoxins from contaminated 
media. The mechanism is based on a physical binding between 
the mycotoxins and the bacterial cell wall components, such 
as polysaccharides and peptidoglycans (Corassin et al., 2013).
Different lactic acid bacteria species, Generally Recognized as 
Safe (GRAS) used as probiotics, have been studied to reduce AFB1 
contamination and/or its bioaccessibility either in a model system 
(phosphate buffer saline solution, PBS) or formulated medium 
(Bovo et al., 2014; Fazeli et al., 2009; Ferrer et al., 2015). However, 
a single study only evaluated AFB1 removal and bioaccessibility 
in milk (Wochner et al., 2019). Moreover, only a small number 
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Abstract
Milk is a key food worldwide prone to mycotoxins contamination. Lactobacillus plantarum and prebiotics detoxification ability 
was evaluated by a Plackett-Burman Design considering the reduction of aflatoxin B1 (AFB1) and its bioaccessibility in artificially 
contaminated ultra-high temperature cow milk. Six variables were evaluated: AFB1 concentration (from 5.0 to 10.0 μg L
−1); incubation 
time (0 to 6 h); and inulin, oligofructose, β-glucan, and polydextrose concentrations (from 0.00 to 0.75%). The reduction in AFB1 
ranged from 0% to 55.85% and in vitro bioaccessibility from 15.62% to 51.09%. The greatest reduction in AFB1 occurred by adding 
L. plantarum combined with inulin, oligofructose and β-glucan. The greatest reduction in bioaccessibility occurred by adding inulin 
or oligofructose and L. plantarum with a 10.0 μg L−1 AFB1 concentration. A sharp reduction in AFB1 was accompanied by higher 
bioaccessibility rates, and in this case, bioaccessibility is considered the main factor to ensure a low AFB1 absorption by the body. 
The best experimental condition was 10.0 µg L-1 AFB1, added of L. plantarum and inulin or oligofructose (0.75%), ensuring > 16% 
final bioaccessibility. Such results represent a safe AFB1 decontamination level for milk.
Keywords: β-glucan, decontamination, inulin, mycotoxin, probiotic.
Practical Application: Probiotic and prebiotic use for a safe AFB1 decontamination procedure in milk.
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of studies describing the prebiotics effect on the AFB1 removal 
and its bioaccessibility (Ferrer et al., 2015; Wochner et al., 2019) 
are found in the literature. The use of proven potential AFB1 
decontaminants such as probiotics combined with prebiotics 
is an attractive alternative that ought to be investigated for the 
mycotoxin decontamination in milk.
This study aimed to evaluate L. plantarum action, both 
isolated and combined with inulin, oligofructose, β-glucan, and 
polydextrose prebiotics on AFB1 reduction and its bioaccessibility 
in whole ultra-high temperature (UHT) milk.
2 Materials and methods
Lyophilized Lactobacillus plantarum BG112 (SACCO, Cadorago, 
Italy) was activated (0.1%; m v−1) in a Man-Rogosa-Sharpe Broth 
(MRS, Merck, Darmstadt, Germany) added with 0.05% L-cysteine 
incubated at 37 ± 1 °C for 12 h (Orion 502, Fanem, São Paulo, 
Brazil). The MRS broth containing active microbial cells was 
centrifuged at 1189 g for 5 min (CT-5000R, Cientec, Brazil), the 
supernatant was then discarded and the microbial pellets were 
resuspended in milk to obtain a 108 CFU mL−1 concentration.
2.1 Milk contamination
The AFB1 standard (Sigma-Aldrich, Saint Louis, Missouri, 
USA) was resuspended in 100 mL benzene: acetonitrile (98:2; v: v) 
to obtain a 10 μg mL−1 stock solution, which was further diluted 
with benzene: acetonitrile (98:2; v: v) to obtain the desired spiked 
concentration (Table 1). The benzene/acetonitrile was evaporated 
in the oven (45  °C, Cienlab, CTM45, Campinas, Brazil) and 
the mycotoxin was resuspended in UHT milk obtained from 
a local market. Beer’s Equation (A = εcl) was used to calculate 
the final solution concentration from the spectrophotometer 
reading (Lambda XLS, PerkinElmer, Baconsfield, UK) at 360 nm 
(Scaglioni et al., 2014).
2.2 AFB1 detoxification in milk
A Plackett-Burman design was used to evaluate AFB1 
reduction and its bioaccessibility in artificially contaminated 
UHT milk (Table 1). The effects of AFB1 concentration (5.0 to 
10.0 μg L−1), incubation time (0 to 6 h), and inulin (Raftiline 
GR, Orafti), oligofructose (Raftilose P95, Orafti), β-glucan 
(ProamOatTM, Tate  &  Lyle), and polydextrose (Litesse, 
DuPont-Danisco) prebiotics were evaluated (each prebiotic 
from 0 to 0.75%; w v-1). Additionally, three control treatments 
(CT) - (1) CT1 milk + AFB1; (2) CT2 milk + L. plantarum; and 
(3) CT3 milk - were performed and incubated for 3 h.
Milk contamination with the desired AFB1 concentration 
(Table 1) was carried out using the AFB1 stock solution. After that, 
prebiotics were dissolved in the UHT milk as described in Table 1 
and sonicated (Elmasonic P60, Elma, Germany) for 5  min 
(28 ± 2 °C; 80 kHz; 150 W). The L. plantarum biomass was added 
and the runs were incubated (403-3D, Nova Ética, Vargem Grande 
Paulista, Brazil) at 37 ± 1 °C for the set time (Table 1). A 15 mL 
aliquot from each run was collected in a falcon tube, frozen at 
-18 °C for 48 h and lyophilized (25 °C, 24 h, 0.05 mBar, FreeZone 
6L, Labconco, Kansas, USA). It was kept frozen and subsequently 
the AFB1 extraction and determination were carried out.
Table 1. Plackett-Burman planning matrix with independent variables and response (dependent variable) of AFB1 reduction (%) and bioaccessibility (%).
Run x1 x2 x3 x4 x5 x6 Reduction (%) Bioaccessibility (%)
1 +1 (10) -1 (0) + 1 (0.75) - 1 (0) - 1 (0) - 1 (0) 7.57d ± 1.56 15.92h ± 0.79
2 +1 (10) +1 (6) -1 (0) + 1 (0.75) - 1 (0) - 1 (0) 22.98c ± 0.60 15.62h ± 0.55
3 -1 (5) +1 (6) + 1 (0.75) - 1 (0) + 1 (0.75) - 1 (0) 0.00 26.53f ± 2.13
4 +1 (10) -1 (0) + 1 (0.75) + 1 (0.75) - 1 (0) + 1 (0.75) 0.00 21.25g ± 1.60
5 +1 (10) +1 (6) -1 (0) + 1 (0.75) + 1 (0.75) - 1 (0) 0.00 20.00g ± 2.00
6 +1 (10) +1 (6) + 1 (0.75) - 1 (0) + 1 (0.75) + 1 (0.75) 30.18b± 1.97 30.76e ± 1.74
7 -1 (5) +1 (6) + 1 (0.75) + 1 (0.75) - 1 (0) + 1 (0.75) 0.00 35.63d ± 0.28
8 -1 (5) -1 (0) + 1 (0.75) + 1 (0.75) + 1 (0.75) - 1 (0) 55.85a ± 0.66 51.09b ± 0.99
9 -1(5) -1 (0) -1 (0) + 1 (0.75) + 1 (0.75) + 1 (0.75) 5.48d ± 0.41 39.34c ± 0.77
10 +1 (10) -1 (0) -1 (0) + 1 (0) + 1 (0.75) + 1 (0.75) 25.43c ± 3.42 26.78f ± 0.81
11 -1 (5) +1 (6) -1 (0) - 1 (0) - 1 (0) + 1 (0.75) 0.00 30.55e ± 0.74
12 -1 (5) -1 (0) -1 (0) - 1 (0) - 1 (0) - 1 (0) 31.45b ± 2.94 27.12f ± 0.93
13 0 (7.5) 0 (3) 0 (0.38) 0 (0.38) 0 (0.38) 0 (0.38) 25.64c ± 1.54 28.01ef ± 0.27
14 0 (7.5) 0 (3) 0 (0.38) 0 (0.38) 0 (0.38) 0 (0.38) 21.71c ± 2.57 21.00g ± 0.39
CT1 (7.5) (3) - - - - < LOQ 101.0
a ± 6.3
CT2 (0) (3) - - - - < LOQ < LOQ
CT3 (0) (3) - - - - < LOQ < LOQ
Independent variables: x1 = AFB1 concentration (μg L
−1); x2 = time (h); x3 = inulin (%); x4 = oligofructose (%); x5 = β-glucan (%); x6 = polydextrose (%); CT1: positive control (milk + 
AFB1); CT2: negative control (milk + L. plantarum); and CT3: negative control (milk only); < LOQ = below the limit of quantification; different superscript letters in columns indicate 
differences by Tukey test (P < 0.05).
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2.3 AFB1 extraction and determination
AFB1 was extracted and purified following the QuEChERS 
method (Quick, Easy, Cheap, Effective, Rugged and Safe) as 
previously described by Sartori et al. (2015) with some modifications. 
The lyophilized runs were resuspended in 15 mL water, added 
with 10 mL hexane and 15 mL acetonitrile acidified with acetic 
acid 1% (v: v) and vortex-stirred for 30 s (LS Logen, Diadema, 
Brazil). After that, 6 g magnesium sulfate (Êxodo Científica, 
Hortolândia, Brazil) and 1.5 g sodium chloride (Synth Ltda, 
Diadema, Brazil) were added to the mixture. The tubes were 
vortex-stirred for 1 min and centrifuged at 1189 g for 7 min 
at 25 °C. The hexane phase was discarded and a 5 mL aliquot 
of acetonitrile phase was collected and oven-dried at 45  °C. 
For AFB1 determination, the dry sample was resuspended in a 
500 μL acetonitrile:methanol:water solution acidified with 1% 
acetic acid (35:10:55) and centrifuged at 3473 g.
AFB1 determination was carried out by Ultra-high-pressure 
liquid chromatography (UHPLC) (Wochner  et  al.,  2019). 
The UHPLC (Ultimate 3000, Thermofisher, Germering, Germany) 
was equipped with an automatic sample injector, quaternary 
pump, oven, and a fluorescence detector (FLD) and controlled 
by Chromeleon 7.2 software. The samples were injected (20 μL) 
in a reverse-phase column (C18 Acclaim PA2, 5 μm Analítica, 
4.6 x 250 mm) at a 35 °C oven temperature. The mobile phase 
comprised of acetonitrile: methanol: water acidified with 1% acetic 
acid (35:10:55) at a 1.0 mL min−1 flow rate. The excitation and 
emission wavelengths were 360 and 450 nm, respectively and the 
chromatographic run time was 10 min. AFB1 identification was 
based on retention time and a co-chromatography was carried 
out using a spike that increased the signal for confirmation. 
AFB1 quantification was performed by external standardization 
using a 6-point calibration curve with measurements in triplicate 
(R2 ≥ 0.998 and P < 0.001). The recovery test was performed 
in triplicate based on samples and 10 µg mL-1spike level. The 
methodology was validated and the linearity, limit of detection 
(LOD), limit of quantification (LOQ), recovery, and relative 
standard deviation (RSD) parameters are seen in Table 2.
2.4 AFB1 reduction and its bioaccessibility determination
The evaluation of AFB1 runs removal percentage was estimated 
taking into account the difference between AFB1 expected 
and real concentrations, divided by real concentration and 
multiplied by 100% (El Khoury et al., 2011). For bioaccessibility 
evaluation, the runs were submitted to an in vitro digestibility 
analysis (Kabak & Ozbey, 2012; Wochner et al., 2019). Milk from 
each run (4.5  mL) was collected, heated, and kept at 37  °C. 
The following steps were used: (1) 6 mL saliva was added to 
milk and incubated for 5 min; (2) 12 mL gastric juice was added 
and the mixture was stirred in a shaker for 2 h (55 rpm); (3) 
simultaneous addition of 12 mL duodenal juice, 6 mL bile, and 
2 mL 1 mol L−1 NaHCO3 and stirred in a shaker for 2 h (55 rpm); 
(4) centrifuged at 2750 g for 5 min at 25 °C. The supernatant 
obtained was lyophilized for further AFB1 extraction, purification, 
and determination as previously described. Bioaccessibility was 
estimated by AFB1 concentration after chyme divided by the 
initial AFB1 concentration, multiplied by 100%.
2.5 Statistical analysis
The results were shown by average ± standard deviation 
and subjected to Analysis of Variance (ANOVA) and Tukey Test 
(p < 0.05), using the Statistica 8.0 software. The studied variables 
effects on the Plackett-Burman Design were also estimated by 
the same software (p < 0.10).
3 Results and discussion
The results for probiotic and prebiotics detoxification ability 
on AFB1 reduction in UHT milk are seen in Table 1. The highest 
AFB1 reduction was obtained for run 8 reaching 55.85%, 
while the reduction for run 12 containing only L. plantarum 
was 31.45%. In contrast, Wochner et al. (2019) observed that 
L. acidophilus combined with prebiotics was as efficient or less 
(13.53% to 35.53%) than only probiotic action (34.96%) on AFB1 
reduction for whole milk. The difference might be due to the 
AFB1 reduction ability by Lactobacillus strain in the presence 
of prebiotics.
Moreover, Peltonen et al. (2001) evaluated the potential of 
twelve Lactobacillus strains to remove AFB1 in phosphate buffer 
saline, with results ranging from 17.3% to 59.7%, highlighting 
28.4% AFB1 reduction for L. plantarum. Additionally, isolated 
L. plantarum reduced AFB1 by 56% using phosphate buffer 
saline (Fazeli  et  al.,  2009). The AFB1 reduction results from 
this article are within the range described in the literature for 
isolated L. plantarum, even when testing contaminated milk, 
which plays a more real condition compared to the phosphate 
buffer saline medium. Moreover, the use of prebiotics improves 
the probiotic development in milk and increases AFB1 reduction 
under specific conditions.
Table 2. Validation parameters of AFB1 determination (n = 3).
Matrix AFB1 spike (μg L
-1) Recovery (%) RSD (%) LOD (μg L-1) LOQ (μg L-1) Linearity R2
Milk
0.5 64.80 8.1





0.9 2.85.0 62.83 8.3 y = 96.9 x + 0.39 0.998
10.0 60.4 1.6
RSD: relative standard deviation; LOD: limit of detection; LOQ: limit of quantification.
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Some Lactobacillus strains have demonstrated potential for 
aflatoxin reduction due to their ability to reduce the carcinogenic 
or toxic effect of food carcinogens. The mechanism is correlated 
to physical binding with either carcinogenic or metabolic 
transformation into less toxic and carcinogenic degradation 
products (El-Nezami et al., 1998). The most accepted theory 
states that a physical bind occurs between the mycotoxin 
and bacterial cell wall components such as polysaccharides, 
peptidoglycans, lipoteichoic acid, and teichoic acid (Bovo et al., 2014; 
Serrano-Niño et al., 2015; Wochner et al., 2018).
In contrast, the interaction between LAB and some 
mycotoxins buildup could occur by specific phenomena such 
as binding. Thus, for runs without AFB1 reduction or with 
lower reduction than run 12 (Table 3), the binding between 
the mycotoxin and probiotic may have been undone, since it 
is reversible and the prebiotics might have affected the binding 
(Oatley et al., 2016). The reversibility of the binding suggests 
an implication of noncovalent type of bounds such as Van der 
Waals and hydrogen bonds (Assaf et al., 2019).
Taking into account Plackett-Burman Design, the use 
of variables within the studied range resulted in statistically 
similar AFB1 reductions (Table 3), reinforcing the efficacy of 
L. plantarum and presenting a promising approach combined 
with prebiotics for AFB1 reduction. Moreover, the addition of 
prebiotics to the runs could foster their functionality on the 
human body improving the AFB1 reduction.
The mycotoxin concentration had no significant effect on AFB1 
reduction, thus the 5:1 to 10:1 μg g−1 mycotoxin: probiotic rate did 
not affect the decontamination process. Similarly, Wochner et al. 
(2019) reported that 3.25 to 6.0  μg L−1 AFB1 concentrations 
did not influence its adsorption rate by L. acidophilus in whole 
milk. It is noteworthy that the combination of probiotics and 
prebiotics presented reduction effects on AFB1 even at higher 
mycotoxin concentrations.
Incubation time had no reduction effect on AFB1 within the 
studied range; which corroborate with the theory described in 
the literature. The aflatoxin-microorganism binding is considered 
a rapid process that occurs within the first minutes of contact. 
A physical adsorption process occurs between the probiotic 
cell wall components and AFB1 instead of covalent binding 
or degradation by bacteria metabolism (Bovo  et  al.,  2013; 
El-Nezami et al., 1998; Shetty & Jespersen, 2006).
All runs presented an AFB1 bioaccessibility reduction 
when compared to the positive control with the lowest values 
observed for run 1 (15.92%) and run 2 (15.62%). The use of 
isolated L. plantarum (run 12) obtained a higher bioaccessibility 
(27.12%), proving the higher inulin or oligofructose efficiency 
when combined with probiotic. On the other hand, the highest 
AFB1 bioaccessibility level was obtained for run 8 (51.09%) 
(Table 1). The obtained bioaccessibility values were lower than 
those reported by Wochner et al. (2019) that described values 
from 23.68% to 72.67% for whole milk treated with L. acidophilus 
and prebiotics, and 34.96% for isolated L. acidophilus. In this 
way, L. plantarum presented a higher bioaccessibility reduction 
efficiency, and a lower bioaccessibility leads to a further reduction 
of toxins available for absorption in the intestine.
The mycotoxin and β-glucan concentration variables presented 
both a negative and positive effect, respectively (p < 0.10) 
(Table 3). Thus, a higher AFB1 concentration and a lower β-glucan 
concentration within the studied range reduced the bioaccessibility. 
Conversely, Meca et al. (2012), when evaluating the effect of 
β-glucan, chitosan, fructooligosaccharides, galattomannan, inulin, 
and pectin added at 1% and 5% concentrations on beauvericin 
bioaccessibility in wheat crispy breads, found that mycotoxin 
binding ability with the prebiotics was higher at a mycotoxin 
concentration of 25 mg L-1 than at 5 mg L-1. However, the type 
and concentration of mycotoxin, and the food matrix studied 
followed a different approach, which justifies the differences 
observed in the current study. Such variation could be linked 
to the occurrence of specific binding sites to prebiotics that 
prevents binding with aflatoxins at the highest concentration.
Time had no effect on bioaccessibility (p > 0.10) which is 
interesting when considering a minimum time for the milk 
decontamination process. On the other hand, the decontamination 
process by L. acidophilus on AFB1 contaminated whole milk 
was significantly influenced by time (Wochner  et  al.,  2019). 
The differences could be linked to the AFB1 concentration studied 
and the potential for Lactobacillus strain binding to mycotoxins.
Although run 1 (inulin) and 2 (oligofructose) showed the 
lowest bioaccessibility values, inulin, oligofructose, and polydextrose 
Table 3. Effect of the variables studied in the Plackett-Burman Design on the AFB1 reduction and bioaccessibility.
Variables
Effect Standard deviation t(7) p-value Effect
Standard 
deviation t(7) p-value
AFB1 reduction AFB1 bioaccessibility
Mean 16.18 5.40 2.99 0.020* 27.49 1.67 16.46 0.000*
AFB1 concentration (µg L
-1) -1.06 11.70 -0.09 0.930 -14.11 3.62 -3.90 0.006*
Time (h) -12.14 11.70 -1.04 0.334 -2.95 3.62 -0.82 0.441
Inulin (%) 1.34 11.70 0.11 0.912 4.41 3.62 1.22 0.262
Oligofructose (%) -0.22 12.58 -0.02 0.987 4.71 3.89 1.21 0.265
β-glucan (%) 9.20 11.70 0.79 0.458 7.28 3.62 2.01 0.084*
Polydextrose (%) -9.43 11.70 -0.81 0.447 3.89 3.62 1.08 0.318
* P < 0.10.
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prebiotics had no significant effect within the studied range, 
which reinforces a greater effect of aflatoxins concentration than 
prebiotics. Runs 1 and 2 carried out with higher AFB1 concentrations 
(10.0 μg L-1) showed bioaccessibility rates from 15.62% to 30.76%, 
lower values compared to those obtained with 5.0 g L-1 AFB1 
concentration (26.53% to 51.09%). Likewise, Meca et al. (2012) 
when studying soluble dietary fibers added to the model solutions 
reported a large beauvericin bioaccessibility reduction to a higher 
mycotoxin concentration (25 mg L-1).
Run 8 was ideal for aflatoxin concentration reduction. 
However, the higher bioaccessibility (51.09%) obtained in this 
run may allow the body to absorb the available AFB1. It was noted 
that a higher AFB1 reduction is not always followed by a lower 
bioaccessibility, which justifies the choice of runs where low 
bioaccessibility prevails over a higher mycotoxin concentration 
reduction, considering the aflatoxins cumulative effect in the 
body. The use of prebiotics inulin or oligofructose (0.75%) plays 
an important role in bioaccessibility reduction, confirmed by 
the percentages obtained in run 1 and 2. Despite the effects 
of probiotics in AFB1 reduction are extensively mentioned, 
(Bovo et al., 2014; El-Nezami et al., 1998; Fazeli et al., 2009; 
Kabak et al., 2009; Wochner et al., 2019) their combination with 
prebiotics is an alternative, especially on reducing bioaccessibility.
4 Conclusion
The sharpest AFB1 reduction (56%) occurred by adding 
L. plantarum individually or combined with inulin, oligofructose 
and β-glucan. The lowest bioaccessibility occurred by adding 
inulin or oligofructose individually with the probiotic. It was 
noted that a sharper AFB1 reduction resulted in a higher 
bioaccessibility rate, which was in this case, the prevalent 
factor. In this respect, the optimal experimental condition 
was achieved using a 10.0 µg L-1 AFB1 concentration added 
with L. plantarum and inulin (0.75%) or oligofructose (0.75%) 
ensuring a < 16% final bioaccessibility. The results portrayed a 
safe decontamination procedure with milk production chain 
application potential.
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